Decreased number of anastomoses in ICAS mice. by Jill M. Roberts (4760685)

AHCC decreases survival of AML cells. by Kavin Fatehchand (4262467)

The blood plasma, kidney, and brain concentration levels (ng/ml) of GSK360A presented for 5 and 24 hours after GSK360A (30 mg/kg) was administered orally by gavage. by Jin Zhou (90734)

Norepinephrine clearance is decreased in the hypoperfused kidney. by Rong Gu (231159)

Decreased expression of DCX in the infected brain. by Manohar B. Mutnal (233165)

G9a decreases Rhox5 expression. by Mayumi Sugimoto (151133)

G9a decreases Rhox5 expression. by Mayumi Sugimoto (151133)

Foxa1 decreases FA uptake. by Marta Moya (188959)

PD 98059 decreases the phosphorylation of ERK in HSVEC, but does not restore ATP-induced decrease in endothelial function in RA. by Padmini Komalavilas (402160)

Decreased mutagen susceptibility of WNV replication complex mutants. by Greta A. Van Slyke (761322)

Removal of <i>Mcs5c</i> TCE copies results in decreased <i>Pappa</i> expression <i>in vitro</i>. by Amanda N. Henning (3043851)

ID8-bearing mice have decreased liver hepcidin mRNA responsive to decreased iron stores. by Airie Kim (544745)

MiR-132-3p was downregulated in TGF-<i>β</i>1 stimulated Met-5A cells and miR-132-3p mimics and miR-132-3p inhibitor transfected Met-5A cells. by Yangyang Yin (14323701)

Subjects:

Palmitate decreases adiponectin expression and secretion. by Shakun Karki (194655)

Jasplakinolide decreased late EPC proliferation. by Xiaoyun Zhang (115529)

Decrease of bnAb activity during cell-cell transmission is variable and strain-dependent. by Lucia Reh (546554)

Virus titers are decreased in irradiated tumors one week after virus therapy. by Brittany A. Umer (14910870)

Inflammatory Adipokines Decrease Expression of Two High Molecular Weight Isoforms of Tropomyosin Similar to the Change in Type 2 Diabetic Patients by Stuart A. Savill (3129060)

Pendrin gene ablation increases force/cross-sectional area and decreases thickness of the aorta. by Roy L. Sutliff (485240)

<i>B-MOBILE</i> - A Smartphone-Based Intervention to Reduce Sedentary Time in Overweight/Obese Individuals: A Within-Subjects Experimental Trial by Dale S. Bond (588506)

“…Average % SED at baseline (72.2%) decreased by 5.9%, 5.6%, and 3.3% [i.e. by mean (95% CI) −47.2(−66.3, −28.2), −44.5(−65.2, −23.8), and −26.2(−40.7, −11.6) min/d] in the 3-, 6-, and 12-min conditions, respectively. …”